Bin Feng

1.8k total citations
35 papers, 431 citations indexed

About

Bin Feng is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Bin Feng has authored 35 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Bin Feng's work include Multiple Sclerosis Research Studies (5 papers), PARP inhibition in cancer therapy (5 papers) and Immunotherapy and Immune Responses (4 papers). Bin Feng is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), PARP inhibition in cancer therapy (5 papers) and Immunotherapy and Immune Responses (4 papers). Bin Feng collaborates with scholars based in China, United States and Denmark. Bin Feng's co-authors include Kaiming Sun, Jing Wang, Lorenzo Federico, Sridhar Ramaswamy, Ningping Feng, Joseph R. Marszalek, Keith Mikule, Gordon B. Mills, Zebin Wang and Christopher P. Vellano and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and PLoS ONE.

In The Last Decade

Bin Feng

28 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Feng China 10 203 115 76 60 48 35 431
Parvin Ataie-Kachoie Australia 6 103 0.5× 137 1.2× 90 1.2× 14 0.2× 32 0.7× 7 376
Mónica Mendoza-Rodríguez Mexico 12 130 0.6× 257 2.2× 83 1.1× 19 0.3× 55 1.1× 36 502
Jiewen Fu China 13 113 0.6× 282 2.5× 61 0.8× 17 0.3× 40 0.8× 47 601
Ranya Hassan Egypt 9 80 0.4× 127 1.1× 209 2.8× 25 0.4× 19 0.4× 22 486
Ahmed Atef Ibrahim United States 11 138 0.7× 284 2.5× 65 0.9× 11 0.2× 50 1.0× 19 540
Zheng Xu China 14 108 0.5× 149 1.3× 175 2.3× 27 0.5× 46 1.0× 34 514
Mahyar Ostadkarampour Sweden 10 86 0.4× 173 1.5× 111 1.5× 45 0.8× 112 2.3× 16 448
Junye Wang China 14 123 0.6× 145 1.3× 133 1.8× 13 0.2× 152 3.2× 42 535
Chun‐Hung Hua Taiwan 14 93 0.5× 189 1.6× 31 0.4× 26 0.4× 100 2.1× 32 545
Po‐Chuan Wang Taiwan 12 148 0.7× 146 1.3× 64 0.8× 26 0.4× 47 1.0× 18 445

Countries citing papers authored by Bin Feng

Since Specialization
Citations

This map shows the geographic impact of Bin Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Feng more than expected).

Fields of papers citing papers by Bin Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Feng. The network helps show where Bin Feng may publish in the future.

Co-authorship network of co-authors of Bin Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Feng. A scholar is included among the top collaborators of Bin Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Feng. Bin Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Tianxiang, et al.. (2025). NEK2 regulates B cell function and the severity of experimental autoimmune encephalomyelitis. Journal of Neuroinflammation. 22(1). 152–152.
4.
Lv, Zehui, Yingjie Wang, Xing-Dong Yang, et al.. (2025). Exosome-integrated biomaterials: A paradigm in musculoskeletal regeneration. Cell Reports Physical Science. 6(10). 102892–102892.
5.
Feng, Bin, et al.. (2024). Assessing the Fidelity of Depression Screening Implementation in Coronary Heart Disease Patients: A Cross‐Sectional Study. Journal of the American Heart Association. 13(21). e035550–e035550.
6.
Zhang, Hailei, Anna Rutkowska, Antonio González-Martı́n, et al.. (2024). Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical Trials. Cancer Research Communications. 5(1). 178–186. 1 indexed citations
7.
McGrail, Daniel J., Yang Li, Roger S. Smith, et al.. (2023). Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins. Cell Reports Medicine. 4(11). 101255–101255. 7 indexed citations
8.
Liu, Ye, Chen Zhang, Tianxiang Zhang, et al.. (2023). Rituximab induces a transient fluctuation of peripheral and follicular helper T cells in neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 382. 578167–578167. 3 indexed citations
9.
Mirza, Mansoor Raza, Gabriel Lindahl, Sven Mahner, et al.. (2022). Ad hoc Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline BRCA Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. Cancer Research Communications. 2(11). 1436–1444. 5 indexed citations
10.
Li, Yue, Jiawen Li, Hui Zhai, et al.. (2022). Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis. BMC Neurology. 22(1). 302–302. 3 indexed citations
11.
Lu, Guofang, Bin Feng, Jianlin Wang, et al.. (2022). A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC. Journal of Inflammation Research. Volume 15. 6729–6743. 6 indexed citations
12.
13.
Han, Long, et al.. (2021). Prevalence and Genotype Distribution of Human Papillomavirus Among Attendees at a Sexually Transmitted Diseases Clinic in Urban Tianjin, China. International Journal of General Medicine. Volume 14. 1983–1990. 13 indexed citations
14.
Wang, Zebin, Kaiming Sun, Yonghong Xiao, et al.. (2019). Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models. Scientific Reports. 9(1). 1853–1853. 178 indexed citations
15.
Mirza, Mansoor Raza, Bin Feng, Ming Shan, et al.. (2019). Elucidation of PARP inhibitor activity in BRCAwt recurrent ovarian cancer by hrr mutational gene profile analysis.. Journal of Clinical Oncology. 37(15_suppl). 5568–5568. 2 indexed citations
16.
Feng, Bin, et al.. (2017). Genital HPV infection among heterosexual and homosexual male attendees of sexually transmitted diseases clinic in Beijing, China. Epidemiology and Infection. 145(13). 2838–2847. 10 indexed citations
17.
18.
Scheuplein, Felix, Sheila Ranganath, Thomas J. McQuade, et al.. (2016). Abstract B30: Discovery and functional characterization of novel anti-PD-1 antibodies using ex vivo cell-based assays, single-cell immunoprofiling, and in vivo studies in humanized mice. Cancer Research. 76(15_Supplement). B30–B30. 3 indexed citations
19.
Chen, Huiling, Dongli Wang, Yingjian Chen, et al.. (2013). Surveillance and analysis of enteroviruses in water environments in Shenzhen from 2010 to 2011. Archives of Virology. 158(6). 1343–1347. 5 indexed citations
20.
Feng, Bin, et al.. (2009). Arterial Switch for Transposition of the Great Vessels and Taussig-Bing Anomaly After Six Months of Age. The Annals of Thoracic Surgery. 88(6). 1948–1951. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parvin Ataie-Kachoie Breakdown of academic impact, for papers by Mónica Mendoza-Rodríguez Breakdown of academic impact, for papers by Jiewen Fu Breakdown of academic impact, for papers by Ranya Hassan Breakdown of academic impact, for papers by Ahmed Atef Ibrahim Breakdown of academic impact, for papers by Zheng Xu Breakdown of academic impact, for papers by Mahyar Ostadkarampour Breakdown of academic impact, for papers by Junye Wang Breakdown of academic impact, for papers by Chun‐Hung Hua Breakdown of academic impact, for papers by Po‐Chuan Wang
Rankless by CCL
2026